Lymphoma: Epigenetic therapy gains momentum
- PMID: 23151602
- DOI: 10.1038/nrc3402
Lymphoma: Epigenetic therapy gains momentum
Comment on
-
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.Nat Chem Biol. 2012 Nov;8(11):890-6. doi: 10.1038/nchembio.1084. Epub 2012 Sep 30. Nat Chem Biol. 2012. PMID: 23023262
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.Nature. 2012 Dec 6;492(7427):108-12. doi: 10.1038/nature11606. Epub 2012 Oct 10. Nature. 2012. PMID: 23051747
References
Publication types
LinkOut - more resources
Full Text Sources
